Please login to the form below

Not currently logged in
Email:
Password:

EMVO appoints general manager

Andreas Walter brings experience from the EFPIA

EMVO Andreas WalterThe European Medicines Verification Organisation (EMVO) has appointed Andreas Walter as its general manager.

Walter will oversee the ongoing set up of a Europe-wide infrastructure for the non-profit organisation.

It was established last year by industry organisations, including EFPIA, and the European Union as part of efforts to implement the European Falsified Medicines Directive (FMD).

Sonia Ruiz, president of the EMVO, said: “We welcome the appointment of Andreas Walter as EMVO general manager who will help the pharmaceutical industry and supply chain get the system up and running effectively to ensure access to safe medicines for European patients.”

Walter brings experience from the European Federation of Pharmaceutical Industries and Associations (EFPIA) where he served as the project director for the FMD.

Most recently, Walter held the position of interim director of the EMVO since February this year.

He said: “I am more than confident that EMVO stands for a successful, innovative governance model, a trusted partner for authorities and patients by building a European-wide verification system for medicines.”

11th April 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...

Infographics